Octant Bio
Octant is seeking a scientist with a strong background in chemical and computational domains to drive small molecule drug discovery programs. The role involves applying cheminformatics and machine learning methods to analyze data, design chemical libraries, and develop predictive models within an iterative, direct-to-biology synthesis platform. This position requires collaboration with medicinal chemists and biologists to shape compound development and enhance computational infrastructure.
Headquarters
Emeryville, California, United States
Company Size
51-200 employees
Founded
2017
Octant is a biotechnology company that combines next‑generation biology, chemistry, and computation to engineer precision medicines. The company focuses on next‑generation small‑molecule therapeutics that modulate complex cellular mechanisms driving disease, rather than only binding purified protein targets. Octant builds and applies large‑scale biology and chemistry platforms aimed at correcting diseases of protein misfolding and mistrafficking. Their platform‑driven approach expands which cellular processes can be drugged to create new treatment opportunities.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Octant Bio.
Octant Bio Appoints Industry Veteran Mark Murcko as Strategic Advisor and Board Member
Oct 14, 2021
Scientific Leader, Integrated Medicinal Chemistry, Computational Chemistry, Cheminformatics and DMPK
Relay Therapeutics
Principal Scientist (Computational Chemistry)
Exelixis
Senior Automation/Medicinal Chemist
Recursion
Computational Chemistry Scientist
Roche
Cheminformatic Scientist
BioLife Plasma Services
Senior Research Scientist - Medicinal Chemist
Elanco